Column

PATIENT PERSPECTIVE

Talking With Patients About Clinical Trials

02/19/2019

Communicating with patients about clinical trials can be a daunting task, especially when many individuals have misconceptions about the nature of clinical trials, confusion about what tasks are involved in...

...

02/19/2019

Journal of Clinical Pathways

Editor's Page

Where We Are With Value Assessment & Innovative Care and Reimbursement Models

12/13/2018

Winston Wong , PharmD;

As the US health care system continues to evolve to value-based care delivery and reimbursement, questions of how to determine what treatments and models produce the most value is imperative. Stakeholders need to...

As the...

12/13/2018

Journal of Clinical Pathways

Counterpoint

Quality Measurement as a Tool for a Patient-Centered Approach to Assessing Value

12/13/2018

Tom Valuck , MD, JD;

Russ Montgomery , PhD, MHS;

Current quality measures usually assess performance against a standard of care for a typical patient rather than the specific patient receiving care, much like value frameworks assess value for a typical patient....

...

12/13/2018

Journal of Clinical Pathways

Viewpoint

Personalized Medicine in a World of Value Frameworks

12/13/2018

Robert W. Dubois , MD, PhD;

Health care treatments are becoming increasingly tailored to individual patients in terms of patient preferences and individual clinical factors. However, these tailored treatments often have a high price tag....

Health...

12/13/2018

Journal of Clinical Pathways

Pharma Insights

ACOs: Changing Health Care Cost and Quality to Be Accountable

12/13/2018

Marylou Buyse , MD, MS;

Maureen Hennessey , PhD, CPCC, CPHQ;

Larry Blandford , PharmD;

Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...

...

12/13/2018

Journal of Clinical Pathways

Clinical Pathways GPS

Value-Based Clinical Pathways in the World of Reference-Priced Medicare Part B Drugs

12/13/2018

Matthew Pakizegee , PharmD, MS;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

The Centers for Medicare & Medicaid Services (CMS) released an advanced notice of proposed rulemaking on October 25, 2018, seeking to test  whether using a combination of 3 approaches—an international drug...

The...

12/13/2018

Journal of Clinical Pathways

Editorial

2018 Editorial Index

12/13/2018

JCP Editors

Download the PDF to view the full Editorial Index of content for 2018 with articles indexed by date, author, and article type. 

...

12/13/2018

Journal of Clinical Pathways

Editor's Page

Working Together: Novel Partnerships and Patient Perspectives

11/19/2018

Winston Wong , PharmD;

The internet has made global communication part of daily life in the United States—a few clicks on a computer or a phrase typed into a search engine can bring almost any type of knowledge to the user’s fingertips....

The...

11/19/2018

Journal of Clinical Pathways

Pharma Insights

Will Any Value Frameworks Gain Acceptance as an Informal Health Technology Assessment in the United States?

11/18/2018

Tricia Garland ;

Stephanie Kennedy , PhD;

Larry Blandford , PharmD;

Todd Edgar , PharmD, MS, SVP;

In recent years, several value frameworks, including the Institute for Clinical and Economic Review, have emerged to help payers assess the value of new drugs. These frameworks highlight efforts to adopt some type of...

In...

11/18/2018

Journal of Clinical Pathways

Business of Pathways

Engaging in Nontraditional Partnerships to Improve Population Health

11/18/2018

Silas Martin , MS;

Robert A. Bailey , MD;

Ira Klein , MD, MBA, FACP;

Population health, which encompasses the health outcomes of a specific group of individuals, has become an important concept in modern health care systems. Many public policy initiatives in recent years have included...

...

11/18/2018

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products